CDL Nuclear Technologies

CDL Nuclear Technologies is the leading U.S. provider of custom Cardiac PET and PET/CT suite solutions, focusing on advanced cardiac imaging to improve diagnostic accuracy and patient outcomes. The company delivers mobile and fixed cardiac PET/CT services, including rubidium-82 generator solutions and operates at national scale. CDL does not develop therapeutic or diagnostic drugs but provides integrated technologies and services for cardiac diagnostics, with a focus on rapid buildouts and flexible service offerings for cardiac care facilities. Published clinical results are not provided, as CDL acts as a solutions provider, not a primary developer of diagnostic agents or therapies.